WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 28-May-2015 (Data received as of 22-May-2015)
Next overall update July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 4'0401 Infant (under 12 months) mortality rate: 192
GDP / capita (US$): 8'0431 Child (under 5 years) mortality rate: 222

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 6'918  6'802  6'687  6'573  6'460  5'350  4'250  3'199 
Births 163  162  160  159  157  150  142  119 
Surviving infants 158  157  155  154  152  145  136  113 
Pop. less than 5 years 771  762  753  745  741  711  658  511 
Pop. less than 15 years 2'221  2'207  2'192  2'178  2'167  2'042  1'759  1'360 
Female 15-49 years 1'787  1'753  1'719  1'685  1'649  1'300  987  724 

Number of reported case

(Click for retrospective incidence data for Paraguay)
Diphtheria 10  14 
Japanese encephalitis
Measles 1'396  745 
Mumps 147  172  247  283  132  527 
Pertussis 101  81  44  11  24  115  652 
Polio*
Rubella 96 
Rubella (CRS)
Tetanus (neonatal) 38  99 
Tetanus (total)** 10  13  50  188 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Paraguay)
Vaccine year result method % card seen                                                
BCG          77  73  75  76  74  79  92  31 
DTP1          78  73  76  77  76  73 
DTP3          74  73  74  76  76  80  80  17 
HepB_BD          78 
HepB3          74  73  74  76  76 
Hib3          74  73  74  76  76 
JapEnc         
MCV          73  75  74  77  77  92  71  19 
MCV2          64  64  62  65  64 
PCV1          78  73  99 
PCV3          71  73  82 
Pol3          74  71  74  75  76  73  78  13 
Rota1          75  71  74  74  69 
Rota_last          72  70  72  72  57 
Rubella1          73  75  74  77  77 
TT2plus 1997  93  MCH     29  33  34  34  55  29 
PAB         
VAD1         
YFV          64  80  34  69  69 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Paraguay)
BCG 90  93  94  92  85  75  31 
DTP1 93  96  97  96  95  86  40 
DTP3 86  87  89  89  86  67  17 
HepB3 86  87  89  89 
HepB_BD
Hib3 86  87  89  89 
MCV 92  91  93  94  92  69  19 
MCV2 81  79  82  81 
PAB 85  85  85  85  47  66  26 
PCV3 73  82 
Pol3 80  83  84  85  86  64  14 
Rota_last 83  85  85  56 

Number of districts in the country 245  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 20
From 80 to 89% 13
From 50 to 79% 52
Less than 50% 15
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 18 months; 4 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HIB 1st contact; Yes immunocompromized
HPV 10 years; +1, +6 months; Yes
HepA 15 months; Yes
HepB_Adult 1st contact; +1, +6 months; Yes risk groups
HepB_Pediatric births; Yes newborns at risk
IPV 2, 4, 6, 18 months; 4 years; Yes risk groups
Influenza_Adult Yes adults with chronic diseases, pregnant women, health care workers and other risk groups
Influenza_Pediatric 6-35 months; Yes children with chronic diseases
MMR 1, 4 years; Yes
MR 1st contact; Yes not vaccinated
MenACWY Yes risk groups
OPV 2, 4, 6, 18 months; 4 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps >= 60 years Yes and risk groups
Rotavirus 2, 4 months; Yes
Td 1st contact; +1 month; +1, +1, +1 year; Yes CBAW and >Y7 and risk group
Tdap 10 years; Yes Pregnant women and risk groups
Typhoid 1st contact; international travelers
Varicella 15-23 months; Yes
YF 12 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  No  No  No 
What years does the MYP cover? number 2'014  2012-2016  2012-2016  2012-2016       
Nº of districts with microplans that include activities to raise immunization coverage number 245  241  240  238  238  234  233 

System performance

Total Nº districts in country number 245  241  240  238  241  234  233 
Nº districts with DTP3 coverage >=80% number 81  78  86  87  86  74  88 
% of districts with DTP3 coverage >=80% From 0 to 100% 33  32  36  37  36  32  38 
Nº districts with measles (MCV1) coverage >=95% number 24  33  27  39  37  27  35 
% of districts with MCV1 coverage >=95% From 0 to 100% 10  14  11  16  15  12  15 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100    99  97  94  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.